West China Journal of Stomatology ›› 2012, Vol. 30 ›› Issue (5): 514-517.doi: 10.3969/j.issn.1000-1182.2012.05.015

Previous Articles     Next Articles

Incidence of human herpes virus 1-4 type in saliva of 245 human immunodeficiency virus-infected patients

Wu Fan1, Zhai Weiwei1, Ge Liuying1, Qi Yanwei2, Gao Hui3, Duan Kaiwen1.   

  1. 1. Dept. of Stomatology, Kunming Medical University Yan’an Hospital, Kunming Yan’an Hospital, Kunming 650051, China; 2. Dept. of AIDS, Kunming Third Hospital, Kunming 650041, China; 3. Dept. of Laboratory Medicine, Kunming Medical University Yan’an Hospital, Kunming Yan’an Hospital, Kunming 650051, China
  • Received:2011-08-16 Revised:2012-07-05 Online:2012-10-01 Published:2012-10-01

Abstract:

Objective To determine the incidence of human herpes virus(HHV) 1-4 type including herpes simplex virus type-1(HSV-1), herpes simplex virus type-2(HSV-2), varicella-zoster virus(VZV), Epstein-Barr virus(EBV)in the saliva of human immunodeficiency virus(HIV)-infected patients. Methods The incidence of salivary HSV-1, HSV-2, VZV and EBV from 245 HIV-seropositive individuals and control group was used to investigate by polymerase chain reaction(PCR) or nested PCR. The data was analyzed by SPSS 18.0 statistical software. Results In the 245 HIV-seropositive individuals, the detection rates of HSV-1, HSV-2, VZV, EBV were 29.0%, 3.3%, 4.1%, 82.0%. In the control group, the detection rates of HSV-1, HSV-2, VZV, EBV were 13.3%, 0, 0, 36.7%. Four HHVs were significantly
more prevalent in the salivas of HIV-seropositive persons than those in the control group(P<0.01). The detection rates of HSV-1, HSV-2, VZV and EBV DNA were no difference between the HIV-positive group with highly active antiretroviral therapy(HAART) and HIV-positive group without HAART(P>0.05). Conclusion There is a high prevalence of HHV infection in HIV-infected people in Yunnan. The most common virus are EBV, followed by HSV-1, but VZV and HSV-2 are rarely detected. HHV co-infection is also observed.

Key words: human immunodeficiency virus, saliva, highly active antiretroviral therapy, human herpes virus